• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Neuberger Berman High Yield Strategies

Neuberger Berman High Yield Strategies

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Omnicell to Present Expanded Medication Management Integration at the European Association of Hospital Pharmacists Congress

    Omnicell to Present Expanded Medication Management Integration at the European Association of Hospital Pharmacists Congress

  2. BJS Biotechnologies to Lead £5m London Consortium Developing Rapid Sepsis Test

    BJS Biotechnologies to Lead £5m London Consortium Developing Rapid Sepsis Test

  3. Seven Bridges Genomics UK to receive £1.95 Million to Launch Graph Genome

    Seven Bridges Genomics UK to receive £1.95 Million to Launch Graph Genome

  4. 225 Learning Centers In Over 175 Locations in India Now Using Thinspace Technology

    225 Learning Centers In Over 175 Locations in India Now Using Thinspace Technology

  5. Observations about Neuberger Berman Closed-End Fund Tender Offers

    Dan Plettner invests and receives income for securities research, including “buy-side” research. Dan licenses his own real time trading data to Covestor Ltd. (“Covestor”), frequently including positions discussed in his Morningstar Contributions. Covestor is a Registered Investment Advisor that ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.